Mobic and Rocephin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mobic (meloxicam) and Rocephin (ceftriaxone sodium). Common drug interactions include gingival swelling among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Mobic and Rocephin. It is created by eHealthMe based on reports of 109 people who take the same drugs from the FDA, and is updated regularly.
What is Mobic?
Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
109 people who take Mobic and Rocephin together, and have interactions are studied.
What are the common drug interactions of Mobic and Rocephin, by gender? *
What are the common drug interactions of Mobic and Rocephin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Mobic and Rocephin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Mobic and Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mobic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mobic and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and ceftriaxone sodium (the active ingredients of Mobic and Rocephin, respectively), and Mobic and Rocephin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Effexor Xr cause Weakness? - 12 seconds ago
- Could Eliquis cause Haemobilia? - 18 seconds ago
- Drug interactions of Bupropion Hydrochloride and Celecoxib - 21 seconds ago
- Could Bicalutamide cause Joint Pain? - 22 seconds ago
- Could Elavil cause Septic Shock? - 22 seconds ago
- Could Gabapentin cause Skin Cancer? - 23 seconds ago
- How effective is Viibryd for Bipolar Ii Disorder? - 25 seconds ago
- Drug interactions of Rybelsus and Linagliptin - 35 seconds ago
- Could Eliquis cause Hair Color Changes? - 40 seconds ago
- Could Metoprolol Tartrate cause Hypertonic Bladder? - 40 seconds ago